Polycythemia Vera. I. Clinical and Laboratory Manifestations

Article1 May 1959POLYCYTHEMIA VERA. I. CLINICAL AND LABORATORY MANIFESTATIONSPAUL CALABRESI, M.D., OVID O. MEYER, M.D., F.A.C.P.PAUL CALABRESI, M.D., OVID O. MEYER, M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-50-5-1182 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptOriginally described by Vaquez1 in 1892, polycythemia vera was established as a definite clinical entity by the subsequent reports of Saundby and Russell2 and Osler3, 4 at the turn of the century. The early historical and investigative accounts of this condition have been thoroughly reviewed in the literature.5, 6, 7By 1940 two distinct contributions had been made which laid the foundation for our present-day concepts of the nature and therapy of the disease: (1) the description of the various clinical stages of the disease by Rosenthal and Bassen,8and (2) the introduction of radioactive phosphorus by Lawrence.9Notwithstanding these... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Madison, Wisconsin*Received for publication March 28, 1958.From the Department of Medicine, University of Wisconsin School of Medicine, Madison, Wisconsin, and the National Cancer Institute, National Institutes of Health, Bethesda, Maryland.†Field Investigator, National Cancer Institute.Requests for reprints should be addressed to Department of Medicine, University Hospitals, Madison 6, Wisconsin. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byChorée révélant une polyglobulie primitiveThrombotic complications of polycythemia veraPolycythemia veraPolycythemia vera: diagnosis and treatment 2002Gastroduodenal lesions in polycythaemia vera: frequency and role of Helicobacter pyloriHyperviscosity syndrome and vertigoHyperviscosity Syndrome and VertigoVertigo in the Hyperviscosity Syndrome4 Polycythaemia and thrombocythaemia in the elderlyProblems of treatment in the neurological complications of Vaquez diseasePOLYCYTHEMIA VERA AND GLOMERULONEPHRITISA case of chorea due to polycythaemia veraFamilial Polycythaemia VeraGASTRIC AND DUODENAL ULCER AND THEIR ASSOCIATED DISEASESSecondary gout associated with chronic myeloproliferative disordersReport of the Joint Committee for Stroke FacilitiesBath PruritusWatch Out for PolycythemiaDie Therapie der Polycythaemia rubra vera Vaquez-OslerLeukemia in Polycythemia Vera Relationship to Splenic Myeloid Metaplasia and Therapeutic Radiation DoseJOHN H. LAWRENCE, M.D., D.SC., F.A.C.P., H. S. WINCHELL, M.D., PH.D., F.A.C.P., W. G. DONALD, M.D., F.A.C.P.Nonatherosclerotic Causes of StrokeJONATHAN LEVINE, M.D., PHILLIP D. SWANSON, M.D.PLATELET ADHESIVENESS IN POLYCYTHAEMIA RUBRA VERAGastric Secretory Function in Polycythaemia VeraFamilial Erythrocytosis A Description of Three Families, One With Hemoglobin YpsilantiKEVIN P. GLYNN, M.D., JOHN A. PENNER, M.D., F.A.C.P., JOSEF R. SMITH, M.D., F.A.C.P., DONALD L. RUCKNAGEL, M.D., PH.D.IV. Miscellaneous arterial lesionsBeneficial Effects of Triacetyl Azauridine in Psoriasis and Mycosis FungoidesPAUL CALABRESI, M.D., RAYMOND W. TURNER, M.D.The Myeloproliferative DisordersSurgery in Polycythemia VeraPolycythemiaPolycythaemia Vera and Essential ThrombocythaemiaANEMIA DUE TO STABLE FACTOR DEFICIENCY IN A PATIENT WITH POLYCYTHEMIA VERA*ANANDA S. PRASAD, M.B., B.S., Ph.D. (Med.)FACTORS CONTROLLING HEMOPOIESIS: EXPERIMENTAL OBSERVATIONS ON THEIR ROLE IN POLYCYTHEMIA VERA*JAMES W. LINMAN, M.D., FRANK H. BETHELL, M.D., F.A.C.P., MARTHA J. LONG, M.S.POLYCYTHEMIA VERA. II. COURSE AND THERAPY*PAUL CALABRESI, M.D., OVID O. MEYER, M.D., F.A.C.P. 1 May 1959Volume 50, Issue 5Page: 1182-1202KeywordsClinical laboratoriesPeptic ulcersPhosphorusPolycythemiaPolycythemia veraResearch laboratories ePublished: 1 December 2008 Issue Published: 1 May 1959 PDF downloadLoading ...